Skip to content

Relieving menstrual pain with modified shoolharan yoga and Trilokya vijaya tablet

Clinical evaluation of modified Shoolharan yoga and Trilokya Vijaya Vati in Dysmenorrhea. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077327
Enrollment
60
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

None listed

Sponsors

Rishikul Campus Uttarakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female Patients married /unmarried of age group 12-45 year will be selected. 2. Pain should be cardinal features. 3. Patients with the complaint of Dysmenorrhea from at least two consecutive cycles which last upto few hours to few days. 4.Patients irrespective of the religion, occupation having fair general condition will be selected for the study.

Exclusion criteria

Exclusion criteria: 1. Dysmenorrhea which require emergency intervention such as faint, acute abdomen pain. 2. Menorrhagia, Metrorrhagia patients should be excluded. 3.Patients existing with disease of cardiovascular, renal or hematopoietic systems and mental diseases will be excluded.

Design outcomes

Primary

MeasureTime frame
Dose and Duration required to relieve mild to moderate pain in the Dysmenorrhea will be assessed on the basis of WaLIDD score.Timepoint: Outcome will be evaluated after 3 days of therapy.

Secondary

MeasureTime frame
Degree of improvement in frequency and duration of pain will be assessedTimepoint: within 72 hours of administration of drug

Countries

India

Contacts

Public ContactAshish Kumar

Rishikul Campus , Haridwar , Uttarakhand Ayurved University

drkhemchand.sharma@gmail.com8006945015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026